Following Congress’s repeal of the FDA’s long-standing animal testing requirement, the Environmental Protection Agency is now ...

The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...

Lee Zeldin, the E.P.A. administrator, revived a plan created during the first Trump administration to end the testing of chemicals on mammals.

India is transitioning from traditional animal testing to advanced human-relevant methods like organoids and AI. This shift ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and sharply reduce costs, while meeting global regulatory standards ...

For decades, animals have served as the default for drug testing, but the biological divide between species is proving costly. Currently, only about 10 percent of drugs that enter human trials receive ...

In 2019, the EPA called for a 30% decrease in animal testing by 2025, and a total phase-out by 2035. The agency under the ...

India should lead the world in promoting alternatives to animal testing in drug discovery and framing non-animal ...